Clinical Trial Update: Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aripiprazole for psychosis in patients with Alzheimer's-type dementia completed; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Dementia, Alzheimer Type | Phase 3 | Status: COMPLETED | Results posted: 2012-03-05